Reverse Remodelling and Remission Markers in the Serial Evaluation of Recent-onset Dilated Cardiomyopathy

Condition:   Dilated Cardiomyopathy Intervention:   Other: 12 months of guideline-directed heart failure therapy Sponsors:   Imperial College London;   Royal Brompton & Harefield NHS Foundation Trust Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials